Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Alleva

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Leukocyte Biology|September 17, 1998
Tumor-induced immune dysfunction: the macrophage connectionK D Elgert, D G Alleva, D W Mullins
Journal of Leukocyte Biology|August 1, 1993
Fibrosarcoma-induced increase in macrophage tumor necrosis factor alpha synthesis suppresses T cell responsesD G Alleva, D Askew, C J Burger, et al.
Immunological Investigations|November 1, 1994
Macrophage priming and activation during fibrosarcoma growth: expression of c-myb, c-myc, c-fos, and c-fmsD G Alleva, D Askew, C J Burger, et al.
Immunopharmacology|August 1, 1997
Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide productionD W Mullins, D G Alleva, C J Burger, et al.
Journal of Leukocyte Biology|March 23, 2001
SJL and NOD macrophages are uniquely characterized by genetically programmed, elevated expression of the IL-12(p40) gene, suggesting a conserved pathway for the induction of organ-specific autoimmunityD G Alleva, E B Johnson, J Wilson, et al.
Diabetes|July 26, 2000
Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic miceD G Alleva, R P Pavlovich, C Grant, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 1997
IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibitionD G Alleva, S B Kaser, M A Monroy, et al.
Clinical Immunology (Orlando, Fla.)|August 8, 2002
Persistence of immune responses to altered and native myelin antigens in patients with multiple sclerosis treated with altered peptide ligandH J Kim, J P Antel, P Duquette, et al.
Scandinavian Journal of Immunology|September 15, 2006
Experimental autoimmune encephalomyelitis develops in CC chemokine receptor 7-deficient mice with altered T-cell responsesA Pahuja, R A Maki, P A Hevezi, et al.
The Journal of Clinical Investigation|February 13, 2001
A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulinD G Alleva, P D Crowe, L Jin, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Leukocyte Biology|September 17, 1998
Tumor-induced immune dysfunction: the macrophage connectionK D Elgert, D G Alleva, D W Mullins
Journal of Leukocyte Biology|August 1, 1993
Fibrosarcoma-induced increase in macrophage tumor necrosis factor alpha synthesis suppresses T cell responsesD G Alleva, D Askew, C J Burger, et al.
Immunological Investigations|November 1, 1994
Macrophage priming and activation during fibrosarcoma growth: expression of c-myb, c-myc, c-fos, and c-fmsD G Alleva, D Askew, C J Burger, et al.
Immunopharmacology|August 1, 1997
Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide productionD W Mullins, D G Alleva, C J Burger, et al.
Journal of Leukocyte Biology|March 23, 2001
SJL and NOD macrophages are uniquely characterized by genetically programmed, elevated expression of the IL-12(p40) gene, suggesting a conserved pathway for the induction of organ-specific autoimmunityD G Alleva, E B Johnson, J Wilson, et al.
Diabetes|July 26, 2000
Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic miceD G Alleva, R P Pavlovich, C Grant, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 1997
IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibitionD G Alleva, S B Kaser, M A Monroy, et al.
Clinical Immunology (Orlando, Fla.)|August 8, 2002
Persistence of immune responses to altered and native myelin antigens in patients with multiple sclerosis treated with altered peptide ligandH J Kim, J P Antel, P Duquette, et al.
Scandinavian Journal of Immunology|September 15, 2006
Experimental autoimmune encephalomyelitis develops in CC chemokine receptor 7-deficient mice with altered T-cell responsesA Pahuja, R A Maki, P A Hevezi, et al.
The Journal of Clinical Investigation|February 13, 2001
A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulinD G Alleva, P D Crowe, L Jin, et al.
Pageof 3